Mirum Pharmaceuticals, Inc. (MIRM) ownership: Top institutional holder: Frazier Life Sciences Management, L.P. ($709.45M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 7679684.00 | $709.45M | 2026-03-31 |
| JANUS HENDERSON GROUP PLC | 6945813.00 | $641.76M | 2026-03-31 |
| BlackRock, Inc. | 3846530.00 | $355.34M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2414776.00 | $223.08M | 2026-03-31 |
| VANGUARD GROUP INC | 2596089.00 | $205.07M | 2025-12-31 |
| FMR LLC | 1965375.00 | $181.56M | 2026-03-31 |
| STATE STREET CORP | 1944281.00 | $179.61M | 2026-03-31 |
| BVF INC/IL | 1584727.00 | $146.40M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 |
Back to MIRM overview · MIRM earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.